Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration [Phase 2]
An open-label Phase 2 clinical trial evaluating the clinical and economic benefits of the I-Ray radiation therapy system for choroidal neova…
-
CLINICAL_TRIALS trial_result · 2013-04-23Clinical Trial Update: iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV) [Phase 1]
Phase 1 trial of iSONEP for treating persistent pigment epithelial detachment in exudative age-related macular degeneration or polypoidal ch…
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration. [Phase 4]
Phase 4 efficacy study evaluating ranibizumab for age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid? [NA]
A completed clinical trial investigated whether Complement Factor H gene polymorphism influences regulation of choroidal blood flow in age-r…
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Microcurrent Stimulation to Treat Macular Degeneration
A completed clinical trial evaluated microcurrent stimulation as a treatment for macular degeneration.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients
A completed clinical trial evaluating whether genetic load influences response to anti-VEGF therapy in Age-related Macular Degeneration.
-
CLINICAL_TRIALS research · 2013-01-29Clinical Trial Update: Impact of Visceral Fat on the Pathogenesis of Age-related Macular Degeneration
This clinical trial update discusses the potential impact of visceral fat on the pathogenesis of age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR) [Phase 3]
This Phase 3 trial compared monthly versus as-needed ranibizumab in patients with subfoveal neovascular age-related macular degeneration, re…
-
CLINICAL_TRIALS research · 2013-01-17Clinical Trial Update: Prospective Study Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye
A clinical trial update from the University of Toronto describes imaging-based investigations of the living human eye to assess retinal oxyg…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation for Two More Years (LUTEGA 2) [NA]
Update on the completed LUTEGA 2 trial evaluating the long-term effects of lutein, zeaxanthin, and omega-3 supplementation on age-related ma…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration [Phase 1, Phase 2]
Phase 1/2 trial evaluating an ocular sirolimus (rapamycin) formulation for age-related macular degeneration with choroidal neovascularizatio…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration [Phase 2]
Phase 2 study of ocular sirolimus in combination with Lucentis for age-related macular degeneration was terminated.
-
CLINICAL_TRIALS trial_result · 2012-12-19Clinical Trial Update: A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD [Phase 1, Phase 2]
A completed Phase 1/2 prospective trial comparing ranibizumab plus dexamethasone versus ranibizumab monotherapy for wet age-related macular …
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD [Phase 3]
Phase 3 trial evaluating safety and efficacy of Anecortave acetate versus placebo in subfoveal CNV due to exudative age-related macular dege…
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD) [Phase 3]
Phase 3 trial update of Anecortave Acetate for subfoveal choroidal neovascularization due to wet age-related macular degeneration; the study…
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Anecortave Acetate Risk-Reduction Trial (AART) [Phase 3]
The Phase 3 Anecortave Acetate Risk-Reduction Trial (AART) for age-related macular degeneration was terminated.
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD) [Phase 3]
Phase 3 trial of anecortave acetate for exudative age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Anecortave Acetate Risk Reduction Trial (AART) [Phase 3]
Phase 3 trial evaluating anecortave acetate for age-related macular degeneration was terminated.
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: A Study of an Implantable Miniature Telescope in Patients With With End-Stage AMD [NA]
This update documents the completion of a clinical trial evaluating the Implantable Miniature Telescope in patients with age-related macular…
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration [Phase 4]
Phase 4 clinical trial update evaluating reduced fluence photodynamic therapy with Visudyne in combination with Lucentis for age-related mac…
-
CLINICAL_TRIALS research · 2012-11-01Clinical Trial Update: IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD [NA]
Clinical trial update indicates the IRay device is being explored to treat polypoidal choroidal vasculopathy secondary to age-related macula…
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Treatment of Age-Related Macular Degeneration With Anecortave Acetate [Phase 2]
A Phase 2 clinical trial evaluating anecortave acetate for age-related macular degeneration has completed.
-
CLINICAL_TRIALS research · 2012-10-25Clinical Trial Update: Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration [NA]
This entry reports a clinical trial update for the Iray device in vascularized pigment epithelial detachment associated with age-related mac…
-
CLINICAL_TRIALS trial_result · 2012-10-24Clinical Trial Update: Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD) [Phase 1]
Phase 1 study evaluating the combination of anecortave acetate and triamcinolone acetonide for exudative age-related macular degeneration ha…
-
CLINICAL_TRIALS trial_result · 2012-10-16Clinical Trial Update: Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy [Phase 1]
A Phase 1 trial of an anti-VEGFR vaccine therapy for neovascular age-related macular degeneration (neovascular maculopathy) has completed.